Brief: Verrica Pharmaceuticals Receives Permanent J-Code (J7354) For YCANTH From Centers For Medicare And Medicaid Services
29/01/2024 14:52
Jan 29 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS RECEIVES PERMANENT J-CODE (J7354)
FOR
YCANTH™ FROM CENTERS FOR MEDICARE AND MEDICAID SERVICES
* VERRICA PHARMACEUTICALS INC: UNDER HEALTHCARE COMMON
PROCEDURE
CODING SYSTEM PROCESS, J-CODE FOR YCANTH™ WILL BECOME FULLY
PUBLISHED APRIL 1, 2024
Source text for Eikon: ID:nGNX6sHHKp
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data